Zoetic International progress towards being a substantial player in the American tobacco-replacement market

Zoetic International plc (LON:ZOE), the London-listed vertically integrated CBD company, has provided a trading update ahead of the Company’s annual general meeting to be held at 3.00pm today and the investor presentation that follows at 4.00pm GMT.

Following a successful trial in a selected beta stores, the Company has received a significant order under one of its existing distribution contracts to roll out stock of its Chill range of tobacco-substitute CBD products in a number of convenience store outlets throughout the USA.  The Directors believe that this is the latest demonstration of the attraction of its Chill brand and marks the “crossing the Rubicon” to full commercialisation that has resulted from excellent consumer feedback during the beta phase.

The transaction to sell the Group’s interest in DTU and the Kansas Nitrogen Assets (as set out in the announcements of 27 May, 8 July and 3 August 2020) to Path Investments plc will not be able to be concluded within the long-stop date included in the original asset purchase agreement, being 31 October 2020.  The Company is currently considering its options and anticipates providing an update to shareholders within the next two weeks.

Antonio Russo, Co-CEO of Zoetic, commented, “We are delighted with this order, which we view as the next important step in our progress towards being a substantial player in the American tobacco-replacement market.”

Trevor Taylor, Co-CEO of Zoetic, commented, “While this further delay to exiting our legacy natural resources business is frustrating, we are determined to ensure we get the best deal for our shareholders.”

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Share on facebook
    Facebook
    Share on twitter
    Twitter
    Share on linkedin
    LinkedIn
    Zoetic International plc

    More articles like this

    Zoetic International plc

    Zoetic International sees significant traction in sales of CBD products

    Zoetic International plc (LON:ZOE), the London-listed vertically integrated CBD company, has announced its interim results for the six months ended 30 September 2020. Highlights ·  Transition from legacy natural resources business to vertically integrated CBD company substantially complete ·    Board

    Zoetic International plc

    Zoetic International investor presentation 29th October 2020

    Zoetic International plc (LON:ZOE), the London-listed vertically integrated CBD company, has announced that its 2020 Annual General Meeting will be held on Wednesday, 28 October 2020, at 3pm (GMT). In connection with the AGM, the Notice of AGM

    Zoetic International plc

    Zoetic International signs its second international distribution contract

    Zoetic International plc (LON:ZOE), the London-listed vertically integrated CBD company, has announced that it has signed its second international distribution contract, as well as continued progress with its core CBD business. Highlights ●  Executed a second international distribution agreement